{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:35:22Z","timestamp":1769571322125,"version":"3.49.0"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dam Med J"],"abstract":"<jats:p>INTRODUCTION. The risk of cancer increases with age. Furthermore, frailty and age-related impairments significantly impact treatment outcomes. With an aging population, it is crucial to ensure a tailored, evidence-based cancer care approach. This study evaluated the extent to which frailty and age-related considerations are incorporated into current Danish national cancer guidelines across six frequent cancer types.\n\nMETHODS. We systematically reviewed all guidelines from the Danish Multidisciplinary Cancer Groups on lung, breast, colorectal, ovarian, bladder and prostate cancer. Guidelines were screened to identify how they address age, frailty, performance status (PS), comorbidity, functional status, general health status and individualised assessment. Identified comments were graded based on their level of specificity and clinical applicability.\n\nRESULTS. All cancer guidelines addressed age and comorbidity. Frailty was explicitly mentioned in four out of six, of which only one guideline provided specific recommendations. PS was frequently included (5\/6), and individualised assessments were encouraged in four of six guidelines, but lacked clarity regarding implementation.\n\nCONCLUSIONS. Danish national cancer guidelines acknowledge age, PS and comorbidity, but lack specific recommendations for frailty assessment and management. By addressing these gaps, we encourage future guidelines to include recommendations on frailty assessment to help clinical decision-making and improve treatment outcomes for older people with cancer.\n\nFUNDING. None.\n\nTRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a06250480","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:23:11Z","timestamp":1768220591000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Addressing geriatric oncology in Danish cancer guidelines to meet future challenges"],"prefix":"10.61409","author":[{"given":"Katharina","family":"Skovhus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian Kirkelund","family":"Bentsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Winther","family":"Lietzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine Lembrecht","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine Henrichsen","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"\u00d8rum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Starup","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Ryg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine Br\u00e6ndegaard","family":"Winther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"ref0","unstructured":"NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 9.3 - 02.10.2023. International Agency for Research on Cancer, 2023. https:\/\/nordcan.iarc.fr\/ (Apr 2025)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ewertz M, Christensen K, Engholm G, et al. Trends in cancer in the elderly population in Denmark, 1980-2012. Acta Oncol. 2016;55(suppl 1):1-6.","DOI":"10.3109\/0284186X.2015.1114678"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.3109\/0284186X.2015.1114678","DOI":"10.3109\/0284186X.2015.1114678"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Williams GR, Mackenzie A, Magnuson A, et al. Comorbidity in older adults with cancer. J Geriatr Oncol. 2016;7(4):249-57. https:\/\/doi.org\/10.1016\/j.jgo.2015.12.002","DOI":"10.1016\/j.jgo.2015.12.002"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cger.2010.08.008","article-title":"Frailty defined by deficit accumulation and geriatric medicine defined by frailty","volume":"27","author":"Rockwood","year":"2011","unstructured":"Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1):17-26.","journal-title":"Clin Geriatr Med"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/j.cger.2010.08.008","DOI":"10.1016\/j.cger.2010.08.008"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ethun CG, Bilen MA, Jani AB, et al. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67(5):362-77. https:\/\/doi.org\/10.3322\/caac.21406","DOI":"10.3322\/caac.21406"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Shaw JF, Budiansky D, Sharif F, McIsaac DI. The association of frailty with outcomes after cancer surgery: a systematic review and meta-analysis. Ann Surg Oncol. 2022;29(8):4690-704. https:\/\/doi.org\/10.1245\/s10434-021-11321-2","DOI":"10.1245\/s10434-021-11321-2"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Dale W, Klepin HD, Williams GR, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293-312. https:\/\/doi.org\/10.1200\/JCO.23.00933","DOI":"10.1200\/JCO.23.00933"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Sedrak MS, Freedman RA, Cohen HJ, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78-92. https:\/\/doi.org\/10.3322\/caac.21638","DOI":"10.3322\/caac.21638"},{"issue":"10314","key":"ref10","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894-904.","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(21)01789-X","DOI":"10.1016\/S0140-6736(21)01789-X"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Guo Y, Ding L, Miao X, et al. Effects of prehabilitation on postoperative outcomes in frail cancer patients undergoing elective surgery: a systematic review and meta-analysis. Support Care Cancer. 2022;31(1):57.","DOI":"10.1007\/s00520-022-07541-1"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1007\/s00520-022-07541-1","DOI":"10.1007\/s00520-022-07541-1"},{"issue":"8","key":"ref14","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.jgo.2023.101585","article-title":"The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: a systematic review","volume":"14","author":"Disalvo","year":"2023","unstructured":"Disalvo D, Moth E, Soo WK, et al. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: a systematic review. J Geriatr Oncol. 2023;14(8):101585.","journal-title":"J Geriatr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101585","DOI":"10.1016\/j.jgo.2023.101585"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chuang MH, Chen JY, Tsai WW, et al. Impact of comprehensive geriatric assessment on the risk of adverse events in older patients receiving anti-cancer therapy: a systematic review and meta-analysis. Age Ageing. 2022;51(7):afac145.","DOI":"10.1093\/ageing\/afac145"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1093\/ageing\/afac145","DOI":"10.1093\/ageing\/afac145"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Soo WK, King MT, Pope A, et al. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev. 2022;3(9):e617-e627. https:\/\/doi.org\/10.1016\/S2666-7568(22)00169-6","DOI":"10.1016\/S2666-7568(22)00169-6"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"105052","DOI":"10.1016\/j.esmoop.2025.105052","article-title":"Representation of geriatric oncology in cancer care guidelines in Europe: a scoping review by the International Society of Geriatric Oncology (SIOG)","volume":"10","author":"Pinker","year":"2025","unstructured":"Pinker I, Lafont C, Liposits G, et al. Representation of geriatric oncology in cancer care guidelines in Europe: a scoping review by the International Society of Geriatric Oncology (SIOG). ESMO Open. 2025;10(5):105052.","journal-title":"ESMO Open"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105052","DOI":"10.1016\/j.esmoop.2025.105052"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Simcock R, Wright J. Beyond performance status. Clin Oncol (R Coll Radiol). 2020;32(9):553-61. https:\/\/doi.org\/10.1016\/j.clon.2020.06.016","DOI":"10.1016\/j.clon.2020.06.016"},{"key":"ref22","unstructured":"Danish Bladder Cancer Group. [National clinical guidelines. Treatment and follow-up of muscle-invasive bladder cancer]. Danish Bladder Cancer Group, 2024. [In Danish: Dansk Bl\u00e6reCancer Gruppe. Nationale kliniske retningslinjer. Behandling og opf\u00f8lgning af muskelinvasiv bl\u00e6rekr\u00e6ft. 2024]. www.dmcg.dk\/siteassets\/arsberetninger-og-udgivelser\/udgivelser\/dablaca_beh_opfolgning_muskelinvasiv_v3.0_admgodk_111024.pdf (Oct 2025)"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Rasmussen LS, Winther SB, Chen IM, et al. A randomized phase II study of full-dose gemcitabine versus reduced-dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01). BMC Cancer. 2023;23(1):552. https:\/\/doi.org\/10.1186\/s12885-023-11035-6","DOI":"10.1186\/s12885-023-11035-6"},{"issue":"5","key":"ref24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S2468-1253(19)30041-X","article-title":"Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial","volume":"4","author":"Winther","year":"2019","unstructured":"Winther SB, Liposits G, Skuladottir H, et al. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2019;4(5):376-88.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/S2468-1253(19)30041-X","DOI":"10.1016\/S2468-1253(19)30041-X"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12885-015-1317-7","article-title":"Diagnostic intervals before and after implementation of cancer patient pathways: a GP survey and registry-based comparison of three cohorts of cancer patients","volume":"15","author":"Jensen","year":"2015","unstructured":"Jensen H, T\u00f8rring ML, Olesen F, et al. Diagnostic intervals before and after implementation of cancer patient pathways: a GP survey and registry-based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15:308.","journal-title":"BMC Cancer"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1186\/s12885-015-1317-7","DOI":"10.1186\/s12885-015-1317-7"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"101983","DOI":"10.1016\/j.canep.2021.101983","article-title":"Routes to diagnosis and the association with prognosis in patients with cancer - a nationwide register-based cohort study in Denmark","volume":"74","author":"Danckert","year":"2021","unstructured":"Danckert B, Falborg AZ, Christensen NL, et al. Routes to diagnosis and the association with prognosis in patients with cancer - a nationwide register-based cohort study in Denmark. Cancer Epidemiol. 2021;74:101983.","journal-title":"Cancer Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1016\/j.canep.2021.101983","DOI":"10.1016\/j.canep.2021.101983"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:06:54Z","timestamp":1769522814000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A06250480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/a06250480","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}